Status:
UNKNOWN
Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty
Lead Sponsor:
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Conditions:
Total Knee Arthroplasty
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Total knee arthroplasty (TKA) is a frequent performed surgery. Many institutions are implementing fast track programs for this surgery and adequate pain management is an important feature. Analgesic d...
Detailed Description
Objectives The aim of this study is to examine the effect of CACB on decreasing opioid consumption, increasing the Quality of Recovery (measured via QoR-15) total score and decreasing opioid-related s...
Eligibility Criteria
Inclusion
- Patients undergoing unilateral primary TKA in the fast track setting.
- Patients older than 21 years of age, with American Society of Anesthesiologists (ASA)
- Physical status I-III
- No alcohol or drug dependency
- Sufficient understand and co-operation about the perineural catheter.
Exclusion
- Perioperative complication or discharge delay leading to hospital admission.
- Chronic opioid use of morphine 30mg equivalent per day for last 2 consecutive weeks.
- Allergy to the study medications;
- Coagulopathy and platelet count \< 105/μL;
- Patients with contraindications to the insertion of an epidural or adductor canal catheter (severe anatomic abnormalities or history of previous surgery at the site of catheter placement).
Key Trial Info
Start Date :
October 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05962970
Start Date
October 4 2023
End Date
December 31 2024
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital, Toronto
Toronto, Ontario, Canada, M5G 1X5